As it is known, in 2022, the Cabinet of Ministers of Ukraine has postponed the enactment of the Technical Regulation on cosmetic products (hereinafter referred to as the Technical Regulation) from August 3, 2022 to August 3, 2024.
Work is currently under way to develop a set of relevant bylaws in order to detail the Technical Regulation's provisions. In particular, according to clause 31 of the Technical Regulation, the Procedure for notifying (providing information) on cosmetic products (hereinafter referred to as the Procedure) shall be established by the Ministry of Health of Ukraine (hereinafter referred to as MOH).
Pursuant to this provision, on May 31, 2023, MOH has released a draft order approving the Procedure on its website.
KEY ISSUES
Amendments to the data on notified cosmetic products shall be made:
Overall, the proposed Procedure defines a more detailed process for notification of cosmetic products than provided in clause 31 of the Technical Regulation.
DISCUSSION
Representatives of cosmetic companies and other interested stakeholders are welcome to participate in the discussion of the draft order within one month of its promulgation.
Should you have any suggestions or comments on the draft order, please send them to MOH in writing or electronically at the address: 7 Hrushevskoho Street, Kyiv, 01601, Pharmaceutical management; phone: (044) 200 0793, (e-mail: moz.pharm@moz.gov.ua).
Details on the Procedure proposed by the draft order are available at the link (in Ukrainian).
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.